chronic weight management Archives

Can Sciwind Biosciences’ ecnoglutide challenge conventional GLP-1 drugs in the expanding obesity market?

By Pallavi Madhiraju on March 8, 2026 Pharma & Biotech

China approves Sciwind Biosciences’ ecnoglutide for weight management. Discover what the biased GLP-1 mechanism could change in the obesity drug race.

Can higher-dose Wegovy reshape the obesity treatment curve for Novo Nordisk?

By Venkatesh B on November 26, 2025 Pharma & Biotech

Novo Nordisk’s semaglutide 7.2 mg dose aims to raise Wegovy’s weight loss impact. Learn how this could shift obesity treatment and reshape clinical norms.